OBJECTIVE: To estimate the contribution of clinically-confirmed diabetes mellitus to tuberculosis (TB) rates in communities where both diseases are prevalent as a way to identify opportunities for TB prevention among diabetic patients. METHODS: This is a prospective study in which TB patients ≥ 20 years old at TB clinics in the Texas-Mexico border were tested for diabetes. The risk of tuberculosis attributable to diabetes was estimated from statistics for the corresponding adult population. FINDINGS: The prevalence of diabetes among TB patients was 39% in Texas and 36% in Mexico. Diabetes contributed 25% of the TB cases studied, whereas human immunodeficiency virus (HIV) infection contributed 5% or fewer. Among TB patients, fewer Mexicans than Texans were aware that they had diabetes before this study (4% and 19%, respectively). Men were also less frequently aware than women that they had diabetes (P = 0.03). Patients who knew that they had diabetes before the study had an 8-year history of the disease, on average, before being diagnosed with TB. CONCLUSION: Patients with diabetes are at higher risk of contracting TB than non-diabetic patients. Integrating TB and diabetes control programmes worldwide would facilitate TB prevention among diabetes patients and increase the number of diabetics who learn of their condition, particularly among males. Such a strategy would lead to earlier case detection and improve the management of both TB and diabetes.
OBJECTIVE: To estimate the contribution of clinically-confirmed diabetes mellitus to tuberculosis (TB) rates in communities where both diseases are prevalent as a way to identify opportunities for TB prevention among diabeticpatients. METHODS: This is a prospective study in which TB patients ≥ 20 years old at TB clinics in the Texas-Mexico border were tested for diabetes. The risk of tuberculosis attributable to diabetes was estimated from statistics for the corresponding adult population. FINDINGS: The prevalence of diabetes among TB patients was 39% in Texas and 36% in Mexico. Diabetes contributed 25% of the TB cases studied, whereas human immunodeficiency virus (HIV) infection contributed 5% or fewer. Among TB patients, fewer Mexicans than Texans were aware that they had diabetes before this study (4% and 19%, respectively). Men were also less frequently aware than women that they had diabetes (P = 0.03). Patients who knew that they had diabetes before the study had an 8-year history of the disease, on average, before being diagnosed with TB. CONCLUSION:Patients with diabetes are at higher risk of contracting TB than non-diabeticpatients. Integrating TB and diabetes control programmes worldwide would facilitate TB prevention among diabetespatients and increase the number of diabetics who learn of their condition, particularly among males. Such a strategy would lead to earlier case detection and improve the management of both TB and diabetes.
Authors: Anthony D Harries; Megan B Murray; Christie Y Jeon; Salah-Eddine Ottmani; Knut Lonnroth; Mauricio L Barreto; Nils Billo; Richard Brostrom; Ib Christian Bygbjerg; Susan Fisher-Hoch; Toru Mori; Kaushik Ramaiya; Gojka Roglic; Hanne Strandgaard; Nigel Unwin; Vijay Viswanathan; David Whiting; Anil Kapur Journal: Trop Med Int Health Date: 2010-04-12 Impact factor: 2.622
Authors: Alfredo Ponce-De-Leon; Ma de Lourdes Garcia-Garcia Md; Ma Cecilia Garcia-Sancho; Francisco J Gomez-Perez; Jose Luis Valdespino-Gomez; Gustavo Olaiz-Fernandez; Rosalba Rojas; Leticia Ferreyra-Reyes; Bulmaro Cano-Arellano; Miriam Bobadilla; Peter M Small; Jose Sifuentes-Osornio Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112
Authors: Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher Journal: Tuberculosis (Edinb) Date: 2018-08-18 Impact factor: 3.131
Authors: A D Harries; S Satyanarayana; A M V Kumar; S B Nagaraja; P Isaakidis; S Malhotra; S Achanta; B Naik; N Wilson; R Zachariah; K Lönnroth; A Kapur Journal: Public Health Action Date: 2013-11-04
Authors: H-Q Qu; A R Rentfro; Y Lu; S Nair; C L Hanis; J B McCormick; S P Fisher-Hoch Journal: Int J Tuberc Lung Dis Date: 2012-01-05 Impact factor: 2.373
Authors: Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel Journal: Chest Date: 2017-04-20 Impact factor: 9.410
Authors: Lenette L Lu; Amy W Chung; Tracy R Rosebrock; Musie Ghebremichael; Wen Han Yu; Patricia S Grace; Matthew K Schoen; Fikadu Tafesse; Constance Martin; Vivian Leung; Alison E Mahan; Magdalena Sips; Manu P Kumar; Jacquelynne Tedesco; Hannah Robinson; Elizabeth Tkachenko; Monia Draghi; Katherine J Freedberg; Hendrik Streeck; Todd J Suscovich; Douglas A Lauffenburger; Blanca I Restrepo; Cheryl Day; Sarah M Fortune; Galit Alter Journal: Cell Date: 2016-09-22 Impact factor: 41.582
Authors: Nira R Pollock; Lilia Macovei; Kelly Kanunfre; Rakesh Dhiman; Blanca I Restrepo; Izelda Zarate; Paula A Pino; Francisco Mora-Guzman; Ricardo T Fujiwara; Gerd Michel; Suely S Kashino; Antonio Campos-Neto Journal: J Clin Microbiol Date: 2013-02-06 Impact factor: 5.948